|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4545 | (2006.01) |
| C07D 403/02 | (2006.01) | ||
| A61P 25/06 | (2006.01) | ||
| C07D 403/12 | (2006.01) |
| (11) | Number of the document | 2413933 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10759491.3 |
| Date of filing the European patent application | 2010-04-02 | |
| (97) | Date of publication of the European application | 2012-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-01 |
| (46) | Date of publication of the claims translation | 2018-02-26 |
| (86) | Number | PCT/US2010/029810 |
| Date | 2010-04-02 |
| (87) | Number | WO 2010/115125 |
| Date | 2010-10-07 |
| (30) | Number | Date | Country code |
| 166097 P | 2009-04-02 | US |
| (72) |
PILGRIM, Alison, US
WHITE, James, F., US
RUPNIAK, Nadia, M., J., US
|
| (73) |
Colucid Pharmaceuticals, Inc.,
2530 Meridian Parkway, Suite 300, Durham, NC 27713,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | 2,4,6-Trifluor-N-[6-(1-metil-piperidin-4-karbonil)-piridin-2-il]-benzamidas migrenos gydymui, skiriant peroraliai arba intraveniniu būdu |
| 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE FOR THE TREATMENT OF MIGRAINE VIA THE ORAL OR INTRAVENOUS ROUTE |
| Payment date | Validity (years) | Amount | |
| 2025-03-19 | 16 | 347.00 EUR |
| 2026-04-02 |